tirzepatide weight loss vs semaglutide efficacy of versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial | Diabetologia Tirzepatide vs. Semaglutide for Weight

Journal of Dietary Supplements

35,36 In 1937, Krebs and Henseleit discovered the tricarboxylic acid (TCA) cycle, which converts pyruvate into carbon dioxide and water under aerobic conditions while generating energy

It is often used to support weight management in addition to blood sugar control

It has demonstrated effectiveness in improving metabolic health and may be especially beneficial for individuals with obesity-related medical problems

Feeling cold is not listed as an official adverse effect in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), though some patients report increased cold sensitivity during treatment

According to the CDC, nearly 74 percent of adults in the U.S